SequelSEC

Bodhi Tree Biotechnology Inc BDTB

Services-Management Consulting Services · CIK 0002041531 · Fiscal year ends 0930

AnnualQuarterlyTTM
Revenue
$10.00K
Fiscal year ended 2026-06-30
Operating income
-$23.20K
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

Bodhi Tree Biotechnology Inc (BDTB) reported revenue of $10.00K and net income of -$23.19K for the fiscal year ended 2026-06-30. This page shows 8 annual periods of income statement, balance sheet and cash flow figures normalized from Bodhi Tree Biotechnology Inc’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Management Consulting Services.

Income

Bodhi Tree Biotechnology Inc income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-06-30
Revenue$10.00K$15.00K$0$12.00K$0$0$5.00K$15.00K
Cost of revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross profitUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating income-$23.20K-$27.93K-$52.95K-$10.69K-$19.98K-$52.18K-$64.78K$9.73K
Net income-$23.19K-$29.20K-$52.95K-$10.69K-$20.77K-$53.43K-$64.78K$9.73K
Research & developmentUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Weighted-average diluted sharesshares 25.44Mshares 25.44Mshares 25.44MUnavailableshares 25.44Mshares 25.44Mshares 25.44Mshares 16.57M
Pretax income-$23.19K-$27.93K-$52.95K-$10.69K-$19.97K-$52.18K-$64.78K$9.73K
Income tax expense$0$1.26KUnavailable$0$800$1.25KUnavailableUnavailable
Diluted EPS$0.00$0.00$-0.01Unavailable$0.00$0.00$0.00$0.00
Selling, general & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
General & administrative$33.20K$42.93K$52.95K$22.69K$19.98K$52.18K$69.78K$5.27K
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

Bodhi Tree Biotechnology Inc balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-06-30
Cash & equivalentsUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Total assets$18.32K$40.52K$69.71K$119.16K$129.85K$150.62KUnavailableUnavailable
Current assetsUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Total liabilities$4.50K$3.50K$3.50KUnavailableUnavailableUnavailableUnavailableUnavailable
Current liabilities$4.50K$3.50K$3.50KUnavailableUnavailableUnavailableUnavailableUnavailable
Total equity incl. NCI$13.82K$37.02K$66.21K$119.16K$129.85K$150.62K$204.05K$59.61K
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
InventoryUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts receivableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
GoodwillUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debtUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts payableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Cash flow

Bodhi Tree Biotechnology Inc cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-06-30
Operating cash flow-$18.76K-$24.62K-$62.04K-$10.11K-$24.65K-$50.13K-$65.28KUnavailable
Capital expendituresUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Investing cash flowUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Financing cash flowUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Net change in cashUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Stock-based compensationUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortizationUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Derived

Bodhi Tree Biotechnology Inc derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-06-30
Free cash flowUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating margin-232.0%-186.2%Unavailable-89.1%UnavailableUnavailable-1295.5%64.9%
FCF marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
SBC / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Current ratioUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Revenue YoY growthUnavailableUnavailable-100.0%Unavailable-100.0%UnavailableUnavailableUnavailable
Net margin-231.9%-194.6%Unavailable-89.1%UnavailableUnavailable-1295.5%64.9%
R&D / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
CapEx / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open BDTB in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-14View SEC filing
10-Q · Filed 2026-05-14View SEC filing
10-Q · Filed 2026-02-13View SEC filing
10-K · Filed 2025-12-29View SEC filing
10-Q · Filed 2025-08-12View SEC filing
10-Q · Filed 2025-05-20View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.